Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Phase I/II Study of Bi-weekly Irinotecan plus Cisplatin in the Treatment of Advanced Gastric Cancer

W. KOIZUMI, M. KURIHARA, A. SATOH, H. TAKIUCHI, S. TANABE, K. SHIMADA, R. IWASAKI and K. SAIGENJI
Anticancer Research March 2005, 25 (2B) 1257-1262;
W. KOIZUMI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: koizumi@med.kitasatou.ac.jp
M. KURIHARA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. SATOH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. TAKIUCHI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. TANABE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. SHIMADA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. IWASAKI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. SAIGENJI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 25 no. 2B 1257-1262
PubMed 
15865075

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received September 7, 2004
  • Revision received February 7, 2005
  • Accepted February 18, 2005
  • Published online March 1, 2005.

Copyright & Usage 
Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. W. KOIZUMI1,
  2. M. KURIHARA2,
  3. A. SATOH3,
  4. H. TAKIUCHI4,
  5. S. TANABE1,
  6. K. SHIMADA3,
  7. R. IWASAKI5 and
  8. K. SAIGENJI1
  1. 1Department of Gastroenterology/Medical Oncology, Kitasato University East Hospital, 2-1-1 Asamizodai, Sagamihara, Kanagawa 228-8520
  2. 2The Tokyo Cooperative Oncology Study Group, 2-4-8 Shibadaimon, Minato-ku, Tokyo 105-0012
  3. 3Department of Internal Medicine, Northern Yokohama Hospital,35-1 Chuo, Chigasaki, Tsukiji-ku, Yokohama, Kanagawa 224-8503
  4. 4Second Department of Internal Medicine, Osaka Medical College, 2-7 Daigakucho, Takatsuki-city, Osaka 569-8686
  5. 5Iwasaki Internal Medicine Clinic, 30-16 Nisikusabukathyou, Shizuoka-city, Shizuoka 420-0866, Japan
  1. Correspndence to: W. Koizumi, Department of Gastroenterology/Medical Oncology, Kitasato University East Hospital, 2-1-1 Asamizodai, Sagamihara, Kanagawa 228-8520, Japan. Tel: +81-42-748-9111, Fax: +81-42-748-5120, e-mail: koizumi{at}med.kitasatou.ac.jp

Cited By...

  • 18 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Anticancer Research: 25 (2B)
Anticancer Research
Vol. 25, Issue 2B
1 Mar 2005
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Phase I/II Study of Bi-weekly Irinotecan plus Cisplatin in the Treatment of Advanced Gastric Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Phase I/II Study of Bi-weekly Irinotecan plus Cisplatin in the Treatment of Advanced Gastric Cancer
W. KOIZUMI, M. KURIHARA, A. SATOH, H. TAKIUCHI, S. TANABE, K. SHIMADA, R. IWASAKI, K. SAIGENJI
Anticancer Research Mar 2005, 25 (2B) 1257-1262;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Phase I/II Study of Bi-weekly Irinotecan plus Cisplatin in the Treatment of Advanced Gastric Cancer
W. KOIZUMI, M. KURIHARA, A. SATOH, H. TAKIUCHI, S. TANABE, K. SHIMADA, R. IWASAKI, K. SAIGENJI
Anticancer Research Mar 2005, 25 (2B) 1257-1262;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Feasibility Study of S-1 plus Weekly Docetaxel Combined with Concurrent Radiotherapy in Advanced Gastric Cancer Refractory to First-line Chemotherapy
  • Google Scholar

More in this TOC Section

  • Feasibility of Computed Tomography-guided Percutaneous Renal Cryoablation Under Local Anesthesia: A Single Center Experience in Taiwan
  • Conversion Surgery for Unresectable Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel
  • Gastric Linitis Plastica: Clinical Characteristics and Outcomes from the National Cancer Database
Show more Clinical Studies

Similar Articles

Anticancer Research

© 2023 Anticancer Research

Powered by HighWire